Canadian Medical Association Journal
Expanding human papillomavirus (HPV) vaccination programs to
include males in Canada will help protect them against HPV-related cancers,
according to an analysis published inCMAJ (Canadian Medical
Association Journal).
HPV
is the most common sexually transmitted disease in Canada and is linked to
cancers of the oral cavity, pharynx, penis, anus and others, in addition to
causing cervical cancer and anogenital warts. Men who have sex with men are at
high risk of HPV-related diseases.
However,
only three provinces -- Alberta, Nova Scotia and Prince Edward Island -- offer
the HPV vaccine to boys through school-based vaccination programs. Manitoba and
Quebec have pledged to extend their programs to boys in fall 2016.
Evidence
indicates that the HPV vaccine is safe and effective.
The
authors cite barriers to adoption of the HPV vaccine in boys that include the
misconception that HPV is only a women's health issue, not receiving a
recommendation from a doctor or health care provider, and concerns over costs;
in provinces where the HPV vaccine is not provided free, the cost of one dose
is about $150, and multiple doses are required.
The
authors recommend that HPV vaccination programs across all Canadian
jurisdictions become gender neutral. To address finite health care resources,
they suggest negotiating with pharmaceutical companies to decrease the cost of
the HPV vaccine and changing the vaccination schedule from 3 to 2 doses, which
is in line with international recommendations.
* Republican wingnut state Representative Justin Price (Richmond, Hopkinton, Exeter) is one of the leading voices against vaccinating young people against the HPV virus which causes several forms of cancer later in life.